Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
November 19, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 07, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek has introduced the world’s first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries.
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Global Single-cell Analysis Market Analysis Report 2024-2030, by Product (Consumables, Instruments), Application (Cancer, Stem Cell), Workflow (Downstream Analysis, Data Analysis), End-use and Region
June 11, 2024 11:19 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Global Single-cell Analysis Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Application (Cancer, Stem Cell),...
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
May 28, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use.
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
May 20, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
March 07, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has opened a 50,000-square-foot facility in Wuxi, China to meet the growing worldwide demand for comprehensive cell analysis solutions
Asia-Pacific Functional Genomics Market Report 2023-2033: Country-Level Insights for Gene Therapy, Drug Discovery & Development, Gene Expression, and Single-Cell Analysis
January 30, 2024 10:42 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Functional Genomics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.As of 2023, the...
Single Cell Genomics and Proteomics in the United States: Public Funding and Large Biopharma Investments Support Technological Advancements and Improved Analysis
January 19, 2024 07:23 ET
|
Research and Markets
Dublin, Jan. 19, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Single Cell Genomics and Proteomics in the United States" report has been added to ResearchAndMarkets.com's offering. In...
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
January 17, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has signed an agreement with The Centre for Genomic Regulation and the Pompeu Fabra University to accelerate scientific discoveries.